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Background: Although adherence to somatic treatment has been studied extensively, adherence to mental health treatment has 
not. In this study, the term treatment adherence is used to refer to adherence to medication regimes and other non-pharmacological 
recommended treatments as part of mental health and psychiatric care. Knowledge of factors connected to adolescents’ 
adherence to such treatment is fairly fragmented. Although treatment staff members are broadly aware of the factors that 
influence adherence, it would be desirable to develop formalized treatment assessment and planning approaches that specifically 
take these factors into account. 
Objective: The purpose of this article is to review the available data related to factors that affect adolescents’ adherence to both 
medication and non-pharmacological treatments in mental health and psychiatric care. 
Methods: A systematic literature search that involved four databases was undertaken. A thematic analysis was conducted on 17 
studies to extract relevant information.  
Results: It appears that an adolescent’s own positive beliefs toward his or her treatment are the main factor that improves his or 
her adherence to that treatment. Good cohesion with close supportive people appears to be positively related to adherence, 
whereas sociodemographic characteristics (e.g., race, gender) were not related.  
Conclusions: By identifying the factors related to the treatment adherence of adolescents, this review article can provide 
guidance to help improve the quality of care and thus further increase adolescents’ satisfaction with their mental health and 
psychiatric treatment. 
 





Adherence among patients with chronic illnesses and 
somatic symptoms has been studied extensively (1). 
Alternatively, adherence to mental health treatment 
has been less studied, with the main focus being the 
medication adherence of adult patients (2-7). Kruse 
and Rohland have investigated adult outpatients’ 
appointment attendance (8); Sellwood and colleagues 
have examined the influence of families in predictions 
of adult patient adherence (9); and Gonzales and 
colleagues have studied patients’ adherence to 
referred mental health treatment (3). The knowledge 
of the factors that are connected to adherence is still 
fairly fragmented. 
Medication non-adherence is related to medication-
taking behavior and is therefore associated with 
poorer treatment outcomes (10). Although definitions 
of the term adherence vary in the current literature, it 
can be defined as the patient taking medication at 
least 75% of the time, with non-adherence used to 
describe the situation when medication is taken less 
than 25% of the time (11). Furthermore, the term 




service engagement can be defined as a multifactorial 
process that involves the acceptance of treatment and 
collaboration with a shared goal of recovery (12). The 
period between discharge from inpatient care and 
engagement with follow-up treatment is especially 
critical; it is also a vulnerable time for patients with 
mental illness who require long-term care (8). 
Especially among adolescents, more information is 
needed to understand the factors that contribute to 
readmission (13). According to Gearing and 
colleagues (14), approximately a third of adolescents 
do not complete recommended psychosocial 
treatment. 
Generally, the main treatments used in mental 
health care are medications and referrals for special 
treatment (3). It is without question that patients’ 
experiences of treatment (e.g., during the acute phase 
of a psychotic disorder) can have an impact on their 
long-term outcomes (15). Several studies involving 
various populations and settings have found a 
connection between patients’ adherence to treatment 
and physician–patient communication. Good and 
effective communication in medical care correlates 
with better patient adherence to treatment (16). It has 
been found that adolescents’ satisfaction with 
treatment is connected to the service environment 
and to the organization of services. There are 
increasing demands to involve adolescents in the 
development of their mental health care; to meet 
these demands, caregivers need to learn more about 
patients’ views related to such care (17). 
Adolescence is a period of rapid physical, 
psychological, and social development. Although 
these changes can induce a range of uncommon 
symptoms and illness patterns, they also present 
unique challenges for communication and 
management (18). These issues must be addressed 
when treating adolescents with mental health 
problems and managing their treatment adherence. 
Because adolescents are growing into adulthood and 
becoming increasingly independent of their parents, 
they are more willing than children to make decisions 
and major life choices for themselves; this can make it 
difficult to induce them to adhere to prescribed 
treatment regimes (19). Non-adherence to treatment 
can lead to illness relapses, readmissions to the 
hospital, and other harmful reactions (20). Non-
adherence is a particularly common problem in 
mental health care, so there is a need to systemically 
investigate treatment adherence among adolescents as 
well as the factors that influence such adherence. As a 
result of the unique aspects of adolescence as a 
developmental stage, adherence among adolescents 
should be examined separately from adherence among 
adults and children. 
In this systematic integrative review, we will focus 
on the factors related to adolescents’ adherence to 
medication and non-pharmacological treatment in 
mental health and psychiatric care. Within the context 
of this article, the terms adherence, compliance, persistence, 
and therapeutic alliance will be used to describe the 
subject being investigated. The term adherence was the 
most prevalent term used in the studies that were 
reviewed. The literature was evaluated to identify the 
factors that relate positively or negatively to 
adolescents’ adherence to treatment. For the purposes 
of this article, an adolescent is someone between the 
ages of 12 and 19 years, and treatment describes all 
methods that have been used to address an 
adolescent’s mental health symptoms, including both 
medication and non-pharmacological treatments. 
 
Methods 
Search Strategy and Process 
We conducted a systematic search of four 
databases—MEDLINE, CINAHL, PsycINFO, and 
Cochrane—for the following keywords: 1) Subject 
headings: patient compliance, treatment compliance, 
mental disorders, psychiatric hospitals, psychiatric 
nursing, psychiatric nurses, psychiatric patients, 
psychiatry, adolescent psychiatry, preventive 
psychiatry, community psychiatry, psychoanalysis, 
psychosomatic medicine, adolescence; and 2) Other 
search terms: adheren*, therapeutic alliance, cooperat*, 
co-operat*, complian*, adolescen*, teen*, young. 
Studies with the following characteristics were 
included: 1) empirical; 2) published between 1990 and 
September 2014; 3) focused on adolescents between 
the ages of 12 and 19 years; 4) about both adolescents 
and children or adults but with results for adolescents 
presented separately; 5) about adolescents with mental 
health problems or illnesses; and 6) about adherence 
to treatment (including adherence to medication and 
other recommended treatments, including therapy, 
appointments, and certain treatment programs). 
Studies were excluded if they primarily focused on the 
following: 1) criminal psychiatry, forensic psychiatry, 
substance abuse, sexual problems, or neuropsychiatric 
illnesses; 2) adolescents with anorexia nervosa with no 
secondary diagnosis of mental illness or anorexia 
nervosa treatment adherence with adherence defined 
entirely in terms of body weight (with no attempt 
made to investigate mental health issues); and 3) child, 
adult, or geriatric psychiatry. In addition, a study 
conducted by the authors was excluded to avoid 




problems of objectivity and to increase the review’s 
validity (21). 
A total of 1042 papers were identified from the 
searches, with 1025 excluded after reading the title (n 
= 572) and then removing duplicates (n = 57); after 
reading the abstract (n = 183); after reading the full 
text (n = 205; 1 paper was not available for 
assessment); and after a quality assessment (n = 7) 
(Figure 1). The two authors read 24 papers to assess 
their quality and their contents in the context of the 
research questions posed for this systematic review. 
We used the Joanna Briggs Institute’s System for the 
Unified Management, Assessment and Review of 
Information package validity checklists (22), which 
include the standard critical appraisal instruments for 
specific study designs: experimental studies, 
interpretive and critical research, narratives, opinion 
and textual papers and observational studies (23). 
Seven papers were excluded chiefly as a result of poor 
descriptions of methods or results that included very 
little information about adolescents’ adherence. A 
total of 17 studies were reviewed, and all included 
articles had to meet the criteria of quality appraisal. 
The authors discussed the quality appraisal and each 
others’ assessments. They had a mutual understanding 
that articles would not be included if they did not 
provide a clear description of the methods used or 
presented results were not clearly based on the 
research questions of this systematic review. 
 
Data Analysis 
Of the studies included, 16 (94%) were quantitative. 
However, they were not sufficiently homogenous to 
allow for statistical pooling for meta-analysis. A 
thematic analysis was conducted on all 17 studies to 
extract all relevant information. Thematic analysis 
involves searching for themes and thus is a method 
used to identify, analyze, and report on the themes 
found within the data. It is a tool that is used to 





The analysis followed five steps: 1) the identification 
of all relevant information; 2) the listing of this 
information (sentences pulled from the articles); 3) 
the coding and summarization of this information 
into a simpler format; 4) the categorization of the 
different codes by theme; and 5) the further review 
and refining of the themes to determine the main 
factors. Finally, coded material was quantified via the 
enumeration of the occurrences of each theme. In this 
integrative systematic review, the themes determined 
by the thematic analysis are the presenting factors on 
which focus will be placed. 
 
Basic Characteristics of the Studies 
One of the studies used a mixed research method 
(25), whereas the rest (n = 16) used quantitative 
research methods. The majority of the studies (n = 
13) examined adherence to medication (25-37), and 
one study dealt with treatment engagement (38). 
Three studies investigated the outcomes of treatment 
and adherence (39-41), and one study focused on 
adherence to therapy (32). 
 




Note. A, substance use disorder; B, with a diagnose of other psychoses; C, secondary diagnoses of depression; D, illicit drug use; E, substance use at baseline; F, Family relationships; G, on acute phase; m, 
medication adherence; m+t, adherence to medication and non-pharmacological treatment; +, positive relation; - , negative relation; x, not related; ≤, is related; * , significant p-value (≤ 0.01); 0, not mentioned 
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Intensity of treatment  0 0 +(m) 0 0 0 +* 0 +(m)* 0 0 +* 0 0 0 0 0 
Positive attitude  0 0 0 0 0 0 0 0 0 + 0 +(m)* 0 + 0 +(m) 0 
Efficacy of medication 
(helpfulness/unhelpfulness) 




0 + + 0 + 0 0 + 
Acceptance of medication  0 0 0 0 0 0 0 0 + 0 0 0 0 0 0 0 0 










0 +* 0 0 + 






0 0 0 0 0 x x 0 0 
Higher incomes  0 0 0 0 0 0 0 0 0 +(m+t)* 0 0 0 0 0 0 0 
Higher severity of symptoms 0 0 0 0 0 0 +* -* 0 + 
 
0 0 - 0 -* 0 0 
Lower severity of symptoms  0 0 0 0 0 0 0 0 0 0 0 0 -* + 0 0 0 
                  






0 0 0 
Readmission  0 -(m)* 0 0 0 0 0 0 0 0 0 0 0 0 -* 0 0 
Risk-taking behavior 0 0 0 0 0 0 +* (D) 
x 
0 x(m) 0 0 0 - 
x (E) 
0 -* 0 0 
Side effects of medication x 0 0 0 0 - 0 0 - 0 0 x 0 0 - 0 0 
Lack of need for medication  0 0 0 0 0 0 0 0 -* 0 0 - 0 0 -* 0 0 
Low family/close friend solidarity  -(m+t) 0 0 0 0 0 x (F) 
 
-(m+t)* 0 0 0 0 -* 0 -* 0 0 
Mother’s mental symptoms  0 0 0 0 0 0 0 -(m+t)* 0 0 0 0 0 0 0 0 0 
Parent/family support  0 0 +(m+t) 0 0 0 - ≤ * 
(m+t) 
+(m) 0 0 
 
-(m) 0 0 0 0 0 
Young age  
 
x(m+t) x(m) x(m) 0 +(m)* (G) 
x 
x x 0 x(m) - 0 0 x x 0 0 - 
Good education of 
adolescent/parent  
0 0 0 0 0 0 - 0 +(m) +* 0 0 0 0 0 0 0 
Race  x(m+t) 0 0 0 0 x(m) 0 0 0 0 x(m) 0 0 0 0 0 0 
Gender  x(m+t) 0 0 0 0 x(m) x 0 0 0 0 0 x x x 0 0 
Family structure  0 0 0 0 0 x(m) x x 0 0 0 0 0 0 0 0 0 
Support of friends  0 0 0 0 0 0 0 0 x(m) 0 0 0 0 0 0 0 0 
Medication type  0 0 0 0 0 x 0 0 0 0 x x x 0 0 0 - 
                  
Initiation of treatment  0 0 0 0 0 0 0 0 x(m) 0 0 0 0 0 0 0 x 
History of mental symptoms or 
illness  
0 x 0 0 0 0 x 
 
0 0 0 0 0 x x 0 0 0 
Symptoms/own feelings about 
symptoms 
0 0 0 0 0 0 x 0 0 x 0 x(m) x x 0 0 x 
School/work  x(m) 0 0 0 0 0 0 0 0 0 0 0 x 0 0 0 0 




Adolescents were outpatients in 14 studies (25-
26;28-34;36-37;39-41) and inpatients of a psychiatric 
center or ward in 6 studies (27;29-30;33;35;38).  
 
Results 
Detailed information about positively and negatively 
related factors is presented in Table 1. Factors have 
been noted with “(m)” if there is a relationship to 
medication treatment and with “(m+t)” if there is a 
relationship to both medication and non-
pharmacological treatment. However, there is no 
specific indicator for factors that are related to non-
pharmacological treatment only. The themes show the 
related factors, which are listed in the table. 
 
Related Factors  
Adolescent’s Positive Beliefs 
These beliefs include an adolescent’s willingness to 
undergo treatment and his or her acceptance of 
treatment, both of which were positively associated 
with adherence. The willingness to undergo treatment 
includes positive cooperation, intensity of treatment, 
and positive attitude. The acceptance of treatment 
includes medication helpfulness, the acceptance of 
medication, and the effects of adherence (see Table 
1). 
 
Life Situation and Close Relationships  
Life situation and close relationships includes 
socioeconomic factors, the cohesion of close people, 
and age and education. Socioeconomic factors include 
the socioeconomic status and income of the 
adolescent’s family. The cohesion of close people 
encompasses the level of solidarity of family and close 
friends, the mother’s mental health, and the level of 
support available from parents and other family 
members. Age and education includes young age and 
good education (see Table 1). 
 
Adolescent’s Illness and Feelings toward Treatment 
This category includes an adolescent’s symptoms and 
his or her negative feelings toward treatment. An 
adolescent’s symptoms can be divided into higher and 
lower severities of symptoms, certain diagnoses, 
readmissions, and risk-taking behaviors (including the 
consumption of tobacco, alcohol, and drugs). 
Negative feelings are influenced by the side effects of 
the prescribed medication, the perceived 
unhelpfulness of the prescribed medication, feelings 
that the prescribed medications are unnecessary, poor 
cooperation with the therapist, and the effects of non-
adherence (see Table 1). 
 
Unrelated Factors  
Adolescent’s or Family’s Life Situation and Social 
Environment 
The life situation and the social environment include 
socioeconomic, demographic, and social environment 
factors. Socioeconomic factors include school, work, 
and socioeconomic status. Demographic factors can 
be further divided into race, gender, and age. Social 
environment factors include the structure of the 
family and the support of friends (see Table 1). 
 
Adolescent’s Treatment and Illness 
The adolescent or his or her family’s treatment and 
illness category includes treatment and illness factors. 
Treatment can be further divided into medication 
type, initiation of treatment, and side effects. Illness 
factors include the adolescent’s history of mental 
illness or its symptoms, risk-taking behavior 
(including tobacco, alcohol, or drug use; fighting; and 
absence without leave), certain diagnoses, and 
symptoms as well as his or her own feelings about 
those symptoms (see Table 1). 




This systematic integrative review identified factors 
that were related positively or negatively to 
adolescents’ adherence to medication and non-
pharmacological treatment in mental health and 
psychiatric care. The main factor that was found to 
improve adherence to treatment was the adolescent’s 
positive beliefs about and therefore acceptance of the 
prescribed treatment. This finding is in accordance 
with those of Bollini and colleagues (42) for 
depressive adults; they reported that one key aspect of 
medication adherence is acceptance of the diagnosis 
and treatment. Passive acceptance in adults might be 
related to attitudes toward taking prescribed 
medication during inpatient treatment; however, 
attitudes can change after discharge (43). Adolescents 
prefer to be treated as individuals and in a non-
judgmental manner—in other words, as people rather 
than as patients (13,16). This type of treatment may 
influence the desire of adolescents to participate in 
the referred and prescribed regimens. For example, it 
has been suggested that more contact with mental 
health professionals improves treatment adherence 
among adolescents (44) and that better-scheduled 
appointments increase adherence (8). This 










suggestion is in line with the findings of this 
systematic review, in which adolescent’s own will to 
undergo treatment was found to be one key factor 
that supported adherence. 
It has also been found that good and planned 
patient education has an important effect on 
medication adherence among patients in somatic care 
(45). According to Gonzales and colleagues (3), a 
greater readiness to engage in treatment will improve 
short-term adherence, and adherence is improved 
when the patient understands the potential benefits of 
treatment. However, a young person with mental 
illness may experience individual discrimination or 
rejection in their social environment (46). It has been 
found that increases and decreases in depressed 
symptoms immediately after treatment changes are 
related to patient expectations. Among adults, patients 
who continued to take antidepressant medications as 
well as those who were switched to placebos had 
higher mean depression rating scale scores (47). 
However, more highly motivated patients showed 
greater responses to placebos as compared with less 
motivated patients, which highlights the importance 
of the patient’s own level of motivation (48). 
An adolescent’s negative feelings toward side 
effects, the perceived unhelpfulness of the 
medication, and the patient’s poor cooperation with 
health care professionals undermine treatment 
adherence. A strong working alliance between adult 
patients and their therapists is consistently positively 
related to medication adherence by those with 
psychotic disorders (49). The presence of a 
cooperative attitude and insight into the illness 
process are some of the main factors related to 
medication adherence when the patient is well (50). 
However, Bollini and colleagues (42) noted that, after 
patients knew about expected side effects, their 
reactions were not particularly negative. 
We found that low solidarity among the family 
members or close friends of the patient had a negative 
influence on the adolescent’s adherence to treatment. 
Families’ experiences of caring for adult relatives with 
bipolar illness have been shown to indirectly influence 
the patient’s medication adherence (51). However, in 
a study of schizophrenic patients (9), the carer’s 
knowledge of the illness was not related to the 
patient’s adherence, although the carer’s experienced 
emotions were related negatively to the patient’s 
adherence. Nevertheless, parental or family support 
was found to be both positively and negatively related 
to treatment adherence in this systematic review. 
Different effects of severity of illness were reported 
with respect to their influence on treatment 
adherence. Increased severity of illness was associated 
with a higher risk of readmission among adolescents 
(13). Sellwood and colleagues (9) found that overall 




symptom severity was not related to non-adherence, 
but they also found that non-adherent patients tended 
to have more severe psychotic symptoms as 
compared with adherent patients. The severity of 
positive psychotic symptoms was not significantly 
associated with adherence (49). Readmission is also 
negatively associated with adherence, because 
adherent patients have a reduced risk of 
rehospitalization (13). 
Although our results showed socioeconomic status 
to be related to adherence to medication in two 
studies, several studies have stated that there is no 
such relationship. However, higher levels of 
education, income, and socioeconomic status of the 
family positively influence adult adherence (7). 
Bulloch and colleagues (2) have stated that age is not a 
predictor of non-adherence among adult patients and 
that, instead, forgetfulness is the main reason for poor 
adherence. 
The findings of this systematic integrative review 
suggest that several factors can have either positive or 
negative influences on an adolescent’s adherence to 
medication or non-pharmacological treatment. The 
inconsistent findings of studies of this subject are 
probably partly explained by differences in the study 
characteristics, including the treatment settings of 
adolescent care and the types of prescribed treatment. 
In particular, whether adolescents are treated in 
inpatient or outpatient settings may influence 
adherence. Outpatients must take on more 
responsibility than inpatients in terms of taking their 
medication on time and attending scheduled meetings, 
and this may reduce treatment adherence among 
adolescents. Conversely, inpatient adolescents are 
assessed and monitored constantly by treatment staff, 
so it is easier to promote compliance. It is important 
to bear in mind that inpatients and outpatients have 
different conditions and treatment regimens that may 
contribute to the observed differences in adherence. 
 
Strengths and Limitations 
The strengths of this systematic integrative review are 
that it involved comprehensive literature searches 
with carefully determined selection criteria defined by 
the two authors and that it included only peer-
reviewed studies. This systematic literature search was 
based on four databases: MEDLINE, CINAHL, 
PsycINFO, and Cochrane. One limitation may be that 
our search did not include Embase, with another 
limitation being that we may not have found all 
relevant studies. A total of 12 articles were excluded 
because their full text was not available or because 
they were written in languages that neither author 
could read nor fully understand. Although the search 
was not limited to only those studies written in 
English, non-English studies could not subsequently 
be used. Some studies were excluded because data 
related to adolescents’ adherence were mixed with 
data for children or adults: our review only included 
studies that had clearly reported adolescents’ 
adherence. This should have increased the validity and 
reliability of our review by ensuring that only the 
factors that specifically influenced adherence among 
adolescents were examined. However, the extent to 
which the factors that influence adherence among 
adolescents differ from those that influence adherence 
among children or adults may be somewhat debatable. 
We excluded studies that focused on adolescents 
from the perspective of forensic or criminal 
psychiatry or that looked at adolescents who had been 
diagnosed with substance use problems, 
neuropsychiatric illnesses, or sexual problems to avoid 
including information about treatment adherence for 
conditions that are treated in very different ways. This 
decision was made in an effort to obtain as much 
consistent and generalized research information as 
possible about adolescents’ treatment adherence in 
mental health and psychiatric care. One of the main 
challenges is that the concept of adherence varies 
both in the literature and across studies. We therefore 
tried to minimize the risk of obtaining fragmented 
research information that applied to adolescents’ 
treatment adherence for different mental illnesses and 
numerous treatment methods. The exclusion criteria 
for this systematic review can thus be considered 
strengths, but they can be considered as limitations as 
well. It is possible that studies that investigated 
illnesses that many adolescents may have (e.g., 
attention-deficit/hyperactivity disorder) or that 
looked at adolescents in forensic psychiatry may have 
been missed. However, forensic psychiatry and the 
treatment of all neuropsychiatric illnesses can be quite 
different as compared with general mental health 
treatment or psychiatric care. We made a purposeful 
decision not to select one or two illnesses of 
adolescents from the exclusion areas, in order to be 
consistent with decided criteria. 
This systematic integrative review was conducted in 
accordance with the guidelines of the Preferred 
Reporting Items for Systematic Review and Meta-
Analyses (52). However, the protocol that was used 
has not been published previously. The current study 
sought to gather information about specific factors 
related to both medication and non-pharmacological 
treatment among adolescents in mental health and 
psychiatric care. The decision to separate adolescents’ 




medication and non-pharmacological treatment to 
investigate these treatments individually is a strength 
of this systematic literature review, because these 
treatment forms are different. Here, medication 
treatment includes prescribed medication only and 
therefore adherence to medication can be counted 
and examined. However, non-pharmacological treat-
ment includes all other types of treatment, including 
appointments for different therapies with different 
clinicians at different outpatient clinics as well as one-
on-one sessions with health care specialists and 
inpatient treatment (excluding medication treatment). 
This study provides detailed information about the 
treatment adherence of adolescents who are receiving 
both outpatient and inpatient care. 
 
Clinical Significance and Conclusions 
For prescribed treatment to be effective, it is essential 
for the adolescent patient to accept and want to 
undergo the treatment. Good social cohesion with 
close people also plays an important role. It is 
important for both the adolescent and his or her 
family to have positive feelings about the treatment. 
By identifying the factors that influence treatment 
adherence, this systematic review may serve as a 
source of guidance for improving mental health and 
psychiatric care quality and for increasing adherence 
and treatment satisfaction among adolescents. 
Treatment staff members are in the best position to 
establish active cooperation with adolescents and their 
families. Such efforts can improve adolescents’ 
treatment adherence, thereby accelerating recovery, 
reducing treatment time, and preventing relapses. 
When treatment staff is made aware of the factors 
related to adherence, treatment assessment and 
planning improve. An adolescent’s adherence to 
treatment can thus also be improved, which 
accelerates recovery, reduces treatment time, and 
prevents relapse. The majority of the articles included 
in this systematic review investigated adolescents who 
were receiving outpatient care and discussed 
medication adherence. More research is needed to 
investigate adolescent’s adherence to treatment during 
inpatient care, with concentration on both medication 
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